Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jul 16, 2026
Reporting period
Not applicable
Filed with the SEC
Jul 18, 2026
CFOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001140361-26-028844
Filed / recorded
Jul 18, 2026, 1:00 AM UTC
Added to OQRO
Oct 6, 2026, 9:54 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
ADMA BIOLOGICS, INC.
Issuer CIK
1368514
Ticker
ADMA
Reporting person
Terry Kohler
Relationship
Officer
Officer title
CFO and Treasurer
Security
Stock Option (Right to Buy)
Table
Derivative (Table II)
Transaction date
Jul 16, 2026
Transaction code
A
Shares / units
136,363
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
136,363
Ownership form
Direct
Amendment
No
Footnotes from the filing
This option was granted to the Reporting Person on July 16, 2026, and will vest over four years, with 25% of the shares subject to the option vesting on the one-year anniversary of the date of grant, and the remaining 75% of the shares subject to the option vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, becoming fully vested on July 16, 2030 in accordance with the Plan, subject to the Reporting Person's continued service as of the applicable vesting date.